Investigation of 6-week versus 6-month clopidogrel therapy in patients with concomitant aspirin and oral anticoagulants therapy after implantation of a drug-eluting stent [Undersogelse af 6-uger versus 6-maneders clopidogrel behandling hos patienter med samtidig aspirin og oral angikoagulans behandling efter implantation af en drug-eluting stent].

Trial Profile

Investigation of 6-week versus 6-month clopidogrel therapy in patients with concomitant aspirin and oral anticoagulants therapy after implantation of a drug-eluting stent [Undersogelse af 6-uger versus 6-maneders clopidogrel behandling hos patienter med samtidig aspirin og oral angikoagulans behandling efter implantation af en drug-eluting stent].

Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Dec 2014

At a glance

  • Drugs Clopidogrel (Primary)
  • Indications Coronary artery disease; Embolism and thrombosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Dec 2014 Status changed from recruiting to completed as reported by European Clinical Trials Database.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top